Search results for "OPD"

showing 10 items of 506 documents

COPD significantly increases cerebral and cardiovascular events in hypertensives

2021

AbstractEssential hypertension and chronic obstructive pulmonary disease often coexist in the same patient. The aim of this study was to evaluate whether the addition of chronic obstructive pulmonary disease modifies the risk of cardiovascular events in hypertensives. We enrolled 1728 hypertensives. Study outcomes included fatal and non-fatal cardiovascular stroke and myocardial infarction, and cardiovascular death. During a mean follow-up of 57 months there were 205 major adverse cardiovascular events (2.47 per 100 pts/yr): cardiac (n117; 1.41 per 100 pts/yr) and cerebrovascular (n = 77; 0.93 per 100 pts/yr). In hypertensives with chronic obstructive pulmonary disease we observed a greater…

Malemedicine.medical_specialtyScienceCardiologyPulmonary disease030204 cardiovascular system & hematologyEssential hypertensionArticleCardiovascular deathPulmonary Disease Chronic Obstructive03 medical and health sciencesMedical research0302 clinical medicineInternal medicinemedicineHumansMyocardial infarctionStrokeAgedessential hypertension; chronic obstructive; pulmonary diseaseCOPDMultidisciplinarybusiness.industryIncidenceIncidence (epidemiology)QRespiratory diseaseRMiddle Agedmedicine.diseaseRisk factors030228 respiratory systemHypertensionCardiologyMedicineFemaleCOPD Hypertensionbusiness
researchProduct

Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction.

2019

Left ventricular ejection fraction (EF) is helpful to differentiate heart failure (HF) phenotype in clinical practice. The aim of the study was to identify simple echocardiographic predictors of post-discharge all-cause mortality in hospitalized HF patients. Patients with acute HF (75 ± 9.8 years), classified in preserved (≥ 50%) and reduced (< 50%) EF (HFpEF and HFrEF, respectively), were enrolled. The mean follow-up period was of 25.4 months. Patients definitively analyzed were 135. At multivariate Cox model, right ventricular diameter (RVd), inferior vena cava diameter (IVCd) and blood urea nitrogen (BUN) resulted to be significantly associated with all-cause mortality in HFpEF (HR 2.…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaHeart Ventricles030204 cardiovascular system & hematologyInferior vena cava03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineBlood urea nitrogenAgedAged 80 and overHeart FailureCOPDEjection fractionbusiness.industryProportional hazards modelheart failure echocardiography mortalityStroke VolumeMiddle AgedWeights and Measuresmedicine.diseasePrognosismedicine.veinItalyEchocardiographyHeart failureEmergency MedicineCardiologyFemalebusinessHeart failure with preserved ejection fractionAll cause mortalityInternal and emergency medicine
researchProduct

Urinary Incontinence in Chronic Obstructive Pulmonary Disease: A Common Co-morbidity or a Typical Adverse Effect?

2019

Urinary incontinence (UI) is defined as a loss of bladder control and is characterized by the complaint of any involuntary leakage of urine. Evidence suggests that the prevalence of UI is higher in subjects with chronic obstructive pulmonary disease (COPD) than in age-matched controls in both sexes. UI is classified as stress, urge, and mixed, and has a considerable impact on quality of life. However, the prevalence of UI in individuals with COPD is mostly unexplored in clinical research and often underestimated in clinical practice. Interestingly, although the involuntary leakage of a small amount of urine during coughing (e.g., stress UI) is among the most plausible causes of UI in patien…

Malemedicine.medical_specialtyUrinary incontinenceAnticholinergic agentsComorbidity03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineQuality of lifeInternal medicineSurveys and QuestionnairesPrevalenceMedicineHumansCOPDPharmacology (medical)030212 general & internal medicineAdverse effectbladderAgedCOPDbusiness.industryUrinary retentionmedicine.diseaseComorbidityClinical researchUrinary IncontinenceQuality of LifeFemaleGeriatrics and Gerontologymedicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

2016

Rüdiger Sauer,1 Michaela Hänsel,2 Roland Buhl,3 Roman A Rubin,4 Marcel Frey,5 Thomas Glaab2,3 1Lung Centre Ulm, Ulm, Germany; 2Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany; 3Pulmonary Department, Mainz University Hospital, Mainz, Germany; 4Pulmonary Specialist Practice, Wiesbaden, Germany; 5Biometrics, Alcedis GmbH, Gießen, Germany Background: Maintaining and improving physical functioning is key to mitigating the cycle of deconditioning associated with chronic obstructive pulmonary disease (COPD). We evaluated the impact of free combination of the long-acting anticholinergic tiotropium plus the long-acting β2-agonist ol…

Malereal-worldTime FactorsnoninterventionalHealth StatusSeverity of Illness IndexCholinergic AntagonistsPulmonary Disease Chronic Obstructivechemistry.chemical_compound0302 clinical medicinetiotropiumDeconditioningPhysical functioningSurveys and QuestionnairesProspective Studies030212 general & internal medicineLungOriginal ResearchCOPDOlodaterolGeneral MedicineTiotropium bromideMiddle AgedBronchodilator AgentsDrug CombinationsTreatment OutcomeFemalemedicine.drugmedicine.medical_specialtymedicine.drug_classInternational Journal of Chronic Obstructive Pulmonary Diseasechronic obstructive pulmonary disease03 medical and health sciencesAdministration InhalationSeverity of illnessmedicineAnticholinergicphysical functioningHumansTiotropium BromideIntensive care medicineAdrenergic beta-2 Receptor AgonistsAgedolodaterolbusiness.industryNebulizers and VaporizersRecovery of Functionmedicine.diseaseBenzoxazines030228 respiratory systemchemistryPhysical therapyObservational studybusinessInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Increased innate and adaptive immune responses in induced sputum of young smokers

2015

Background and objectives: It is known that chronic obstructive pulmonary disease (COPD) development process is imperceptible and can be asymptomatic for 20 or more years. It is of great importance to diagnose early inflammatory changes that can lead to COPD in young asymptomatic cigarette smokers. The aim of our study was to analyze the cell spectrum of induced sputum (IS) of young cigarette smokers, with emphasis on T-regulatory cells. Materials and methods: A total of 20 healthy nonallergic smokers, 20 nonsmokers and 20 COPD patients were enrolled in the study. After lung function measurements were taken, we performed sputum induction and analyzed sputum cells. We evaluated the cell coun…

Medicine(all)Medicine (General)COPDbusiness.industryChronic obstructive pulmonary diseaseLymphocyteSmokingImmunocytochemistryChronic obstructive pulmonary disease; T regulatory lymphocytes; Sputum induction; Smokingmedicine.diseaseAsymptomaticrespiratory tract diseasesStainingSputum inductionR5-920medicine.anatomical_structureImmune systemAutomotive EngineeringImmunologymedicineSputummedicine.symptombusinessCD8T regulatory lymphocytesMedicina
researchProduct

Severity-Related Changes of Bronchial Microbiome in Chronic Obstructive Pulmonary Disease

2014

ABSTRACT Bronchial colonization by potentially pathogenic microorganisms (PPMs) is often demonstrated in chronic obstructive pulmonary disease (COPD), but culture-based techniques identify only a portion of the bacteria in mucosal surfaces. The aim of the study was to determine changes in the bronchial microbiome of COPD associated with the severity of the disease. The bronchial microbiome of COPD patients was analyzed by 16S rRNA gene amplification and pyrosequencing in sputum samples obtained during stable disease. Seventeen COPD patients were studied (forced expiratory volume in the first second expressed as a percentage of the forced vital capacity [FEV 1 %] median, 35.0%; interquartile…

Microbiology (medical)medicine.medical_specialtyCOPDVital capacityBacteriologyDiseaseBiologyrespiratory systemmedicine.diseaseSpearman's rank correlation coefficientGastroenterologyrespiratory tract diseasesStable DiseaseInterquartile rangeInternal medicineImmunologymedicineSputumMicrobiomemedicine.symptom
researchProduct

Human Immunodeficiency Virus Infection and Diverse Physical Health Outcomes: An Umbrella Review of Meta-analyses of Observational Studies.

2019

Abstract Background Our aim was to assess both the credibility and strength of evidence arising from systematic reviews with meta-analyses of observational studies and physical health outcomes associated with human immunodeficiency virus (HIV) but not acquired immunodeficiency syndrome. Methods We performed an umbrella review of observational studies. Evidence was graded as convincing, highly suggestive, suggestive, weak, or nonsignificant. Results From 3413 studies returned, 20 were included, covering 55 health outcomes. Median number of participants was 18 743 (range 403–225 000 000). Overall, 45 (81.8%) of the 55 unique outcomes reported nominally significant summary results (P < .05). O…

Microbiology (medical)medicine.medical_specialtyPopulationcomorbidHIV InfectionsDisease03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)Meta-Analysis as TopicPre-EclampsiaPregnancyInternal medicineMedicineHumanshealth outcomes030212 general & internal medicineeducationArticles and CommentariesCOPDeducation.field_of_studyhuman immunodeficiency virusumbrella reviewbusiness.industryhuman immunodeficiency viruPublic healthIncidence (epidemiology)IncidenceAn Umbrella Review of Meta-analyses of Observational Studies.- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 [Grabovac I. Veronese N. Stefanac S. Haider S. Jackson S. Koyanagi A. Meilinger M. Stubbs B. Firth J. Soysal P. et al. -Human Immunodeficiency Virus Infection and Diverse Physical Health Outcomes]HIVmedicine.diseaseComorbidityObservational Studies as TopicInfectious DiseasesCross-Sectional StudiesAcademicSubjects/MED00290health outcomeFemalebusiness030217 neurology & neurosurgeryCohort studySystematic Reviews as TopicClinical infectious diseases : an official publication of the Infectious Diseases Society of America
researchProduct

Co-living jeb kopā dzīvošanas koncepts

2019

Diplomdarba tēma – co-living jeb kopdzīvošanas koncepts kā 21.gadsimta mājokļa alternatīva. Diplomdarba mērķis ir co-living jeb kopā dzīvošanas interjera izveide, integrējot to kādā no pilsētas centra dzīvokļu namiem Darbs sastāv no trīs daļām - teorētiskās, empīriskās un radošās daļas. Teorētiskajā daļā tiks veikts pētījums par mājokļa jēdzienu, komūnu dzīvošanu un to vēsturi, co-housing un co-living jēdzienu un to vēsturi un attīstību mūsdienu kontekstā. Empīriskajā daļā tika izpētīti interjeri, kuros tiek pielietoti co-living principi pasaulē Diplomdarbs sastāv no 4 nodaļām, 13 apakšnodaļām un 3 pielikumiem. Tā apjoms ir 101 lappuse. Darbā izmantoti 51 literatūras avoti. Radošajā daļā ti…

Mākslas zinātnekopdzīvošanakomūnailgtspējībainterjera dizains
researchProduct

Fusion of the

2015

Chronic obstructive pulmonary disease, COPD, affects the condition of the entire human organism and causes multiple comorbidities. Pathological lung changes lead to quantitative changes in the composition of the metabolites in different body fluids. The obstructive sleep apnea syndrome, OSAS, occurs in conjunction with chronic obstructive pulmonary disease in about 10–20 % of individuals who have COPD. Both conditions share the same comorbidities and this makes differentiating them difficult. The aim of this study was to investigate whether it is possible to diagnose a patient with either COPD or the OSA syndrome using a set of selected metabolites and to determine whether the metabolites t…

NMR spectroscopyOriginal ArticleChronic obstructive pulmonary disease (COPD)ChemometricsObstructive sleep apnea syndrome (OSAS)Discriminant modelsrespiratory tract diseasesMetabolomics : Official journal of the Metabolomic Society
researchProduct

Correction to: When kidneys and lungs suffer together

2019

A significant interaction between kidneys and lungs has been shown in physiological and pathological conditions. The two organs can both be targets of the same systemic disease (eg., some vasculitides). Moreover, loss of normal function of either of them can induce direct and indirect dysregulation of the other one. Subjects suffering from COPD may have systemic inflammation, hypoxemia, endothelial dysfunction, increased sympathetic activation and increased aortic stiffness. As well as the exposure to nicotine, all the foresaid factors can induce a microvascular damage, albuminuria, and a worsening of renal function. Renal failure in COPD can be unrecognized since elderly and frail patients…

Nephrologymedicine.medical_specialtyNephrologybusiness.industryPublished ErratumInternal medicinePulmonary renal syndromeMEDLINEmedicineCOPDmechanical ventilationIntensive care medicinebusiness
researchProduct